Blinatumomab, CAS 853426-35-4

Product Description: Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia[1].

Applications: Cancer-programmed cell death

Formula: N/A

References: [1]Kantarjian H, et, al. Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia. N Engl J Med. 2017 Mar 2;376(9):836-847.

CAS Number: 853426-35-4

Molecular Weight: N/A

Compound Purity: 98.78

Research Area: Cancer

Solubility: H2O

Target: CD19

• Artikelnummer: MEXHY-P9963-500UG
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P9963-500UG
• Verpackungseinheit: 500 μg
• Mengeneinheit: STK
• Konjugat: Unconjugated